Psoriasis was less likely to progress to psoriatic arthritis (PsA) among patients treated with interleukin-17 (IL-17) or ...

Biologics are more targeted than other psoriasis treatments. They’re also more expensive, and you take them less frequently. Doctors usually prescribe them for moderate to severe psoriasis.

Psoriasis is a chronic skin disease that manifests itself mainly with skin symptoms (dryness, itching, scaly skin, abnormal patches and plaques). It affects about 2% of the population and is mediated ...

Biologics often help when other treatments haven’t worked to treat psoriasis. They’re synthetic versions of proteins created from human cells that target specific parts of your immune system.

Age at initiation of treatment and the type of biologic therapy prescribed effect the rate of drug survival among patients with psoriasis.

As a group, these new medications are commonly referred to as "biologics" and represent the most current attempt to target specific steps in the immune mechanisms underlying psoriasis. It is the ...

Based on the immunopathology of psoriasis, we have proposed a model for biologic therapeutic approaches ... of these events was similar in all treatment groups (approximately 5%).

The condition that Aaron Ribner battles is psoriasis ... ravaging the skin. Treatments include phototherapy, steroids, topicals, and newer biologic agents which suppress the immune response.